Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |